Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Fast PET/MRI Protocol Cuts Breast Cancer Scan Times in Half

By HospiMedica International staff writers
Posted on 01 Jun 2023

Accurate staging is essential for women who have just been diagnosed with breast cancer, and PET/MRI has started to gain traction as a method for both local and whole-body staging. More...

However, the duration of these hybrid exams poses a significant hurdle in their widespread adoption. Now, researchers have found that the time for breast cancer imaging via PET/MRI can be reduced by half without sacrificing crucial diagnostic data. This discovery could potentially boost the usage of this method for breast cancer diagnosis and increase efficiency within radiology departments.

Researchers at the University of Dusseldorf (Dusseldorf, Germany) managed to reduce the duration of F-18 FDG-PET/MRI protocols from 20 minutes to less than 10 minutes in scans of breast cancer patients with small tumors, without missing any vital findings. To see if the exams could be expedited, the researchers carried out a study involving 90 women newly diagnosed with T1 and T2 breast cancer. These women underwent breast F-18 FDG-PET/MRI scans, after which the researchers utilized software to reconstruct the imaging data and simulate PET acquisition times at 20, 15, 10, and five minutes. Nuclear medicine and breast imaging radiologists subsequently examined and compared the images in random order, evaluating their quality.

The readers identified 127 congruent breast lesions across all PET reconstructions. There were no significant differences in subjective image quality between the 20-, 15-, 10-, and five-minute acquisition times when comparing the T1 and T2 subgroups, as per the research team. Specifically, they found that the breast F-18 FDG-PET/MRI protocols could be reduced from 20 to approximately eight minutes without losing any vital diagnostic data. This research is the first of its kind to assess fast breast F-18 FDG-PET/MRI scans in this patient group, according to the researchers. However, they recommend further studies to confirm their findings.

"[F-18 FDG-PET/MRI] is of great importance due to its local tumor staging and phenotyping abilities and should not be skipped aiming towards faster examination protocols," the group noted. "Reducing the time of PET data acquisition while implementing a shortened but still diagnostic breast MRI protocol might solve the problem of long examination times."

Related Links:
University of Dusseldorf 


Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Surgical System
Stealth AXiS
Tourniquet System
heidi– mein Tourniquet
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Artificial Intelligence

view channel
Image: Artificial intelligence (AI) standalone performance and reader performance with versus without AI assistance. (A) Receiver operating characteristics (ROC) curve for AI standalone performance in the US dataset (AUC 0.899, 95% CI 0.858 to 0.939). (B) ROC curve for AI standalone performance in the Korean dataset (AUC 0.963, 95% CI 0.946 to 0.975). (C) Pooled reader ROC without (AUC 0.718) versus with (AUC 0.852) AI assistance in the Korean dataset; P<0.001. AUC, area under the receiver operating characteristics curve. (Leonard Sunwoo et al., Journal of NeuroInterventional Surgery (2026). DOI: 10.1136/jnis-2026-025339)

AI Improves Non-Contrast CT Interpretation for Time-Sensitive Stroke Assessment

Acute ischemic stroke occurs when a blood vessel in the brain becomes blocked, requiring rapid diagnosis to enable timely reperfusion therapy. Emergency departments often use computed tomography angiography... Read more

Critical Care

view channel
Image Credit: Adobe Stock

Noninvasive Imaging Approach Aims to Detect Basal Cell Carcinoma Before It Becomes Visible

Basal cell carcinoma is the most common form of skin cancer and can damage nearby structures such as the nose or eyes when it develops on the face. Diagnosis typically depends on visible skin changes,... Read more

Surgical Techniques

view channel
Image: Associate Professor Menglin Chen studies how the light-sensitive nanoparticles affect living cells. The screen shows calcium being released inside a cell after nanoparticles taken up by the cell are exposed to blue light. Calcium plays an important role in cellular signaling, and the experiment helps the researchers understand how the nanoparticles can translate light into biological activity. (Photo courtesy of Aarhus University, Johanne Holm Jensen)

Light-Activated Nanoparticles May Offer New Approach to Retinal Prostheses

Retinitis pigmentosa is a degenerative retinal disorder in which photoreceptors progressively die, reducing visual signals to the brain while leaving surviving inner retinal circuits underused.... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.